Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Devices
MedTech
Investor syndicate takes majority stake in HistoSonics
A group of more than a dozen international investors has bought a majority stake in HistoSonics as the company looks to grow its sonic tumor therapy.
Conor Hale
Aug 7, 2025 1:16pm
FTC aims to stop Edwards’ acquisition of JenaValve
Aug 7, 2025 11:33am
Orchestra BioMed scores $111M, backed by Medtronic, Ligand
Aug 5, 2025 3:41pm
Alcon sees Staar Surgical for $1.5B deal
Aug 5, 2025 11:00am
FDA formally kicks off medical device user fee negotiations
Aug 4, 2025 4:45pm
Baxter cuts financial forecasts, pauses infusion pump shipments
Aug 1, 2025 12:00pm
